Explore IgA nephropathy, a rare autoimmune kidney disease where the IgA protein builds up in the kidneys. Normally, IgA helps protect against infections, but in this condition, it changes shape and sticks to other proteins, causing inflammation and damage. This can lead to kidney scarring and impaired function. Early detection and treatment are crucial for managing the disease and protecting kidney function.
Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana V. Rizk, MD, professor of medicine, University of Alabama at Birmingham; and Gerald Appel, MD, professor of medicine and co-director of the Center for Glomerular Disease, Columbia…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
This video discusses the management of IgA nephropathy, a common and incurable kidney disease. Treatment aims to control the disease and delay kidney damage progression. Lifestyle changes, such…
Sean Converse was diagnosed with IgA nephropathy in late 2022 following an acute upper respiratory illness. Sean discusses challenges and his experience with IgA nephropathy.
Dawn J. Caster, MD, FASN, associate professor of medicine, Division of Nephrology & Hypertension, University of Louisville School of Medicine, Louisville, Kentucky, discusses IgA nephropathy, including when to…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Jonathan Barratt, MD, consultant nephrologist and professor of renal medicine, University of Leicester and John Walls Renal Unit, Leicester, provides a comprehensive overview of IgA nephropathy. Professor Barratt…
Professor Jonathan Barratt, head of the Renal Research Group within the College of Life Sciences at the University of Leicester, discusses the latest advancements in the treatment of…
This video discusses the risk factors for IgA nephropathy, a disease with no single known cause. While anyone can develop it, certain groups are at higher risk, including…
